Skystar Bio Pharmaceutical Company (NasdaqCM:SKBI) is seeking acquisitions. Skystar Bio Pharmaceutical is planning to raise $5 million from registered direct offering and plans to use part of proceeds for acquisitions too. Skystar Bio Pharmaceutical said, "The Company shall use a portion of the proceeds of the offering for acquisitions, licenses of new vaccine and aquaculture products, research & development and other general corporate purposes."
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 0 | |
+26.92% | 42.68B | |
-2.92% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.93% | 24.94B | |
-20.70% | 18.96B | |
+28.92% | 12.3B | |
-2.52% | 11.95B | |
-1.13% | 11.55B |
- Stock Market
- Equities
- SKBI Stock
- News Skystar Bio-Pharmaceutical Company
- Skystar Bio Pharmaceutical Mulls Acquisitions